Arbutus Biopharma
ABUS
ABUS
51 hedge funds and large institutions have $81.7M invested in Arbutus Biopharma in 2015 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
61% less capital invested
Capital invested by funds: $212M → $81.7M (-$131M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
51
Holding in Top 10
–
Calls
$469K
Puts
$246K
Top Buyers
| 1 | +$3.42M | |
| 2 | +$1.22M | |
| 3 | +$1.09M | |
| 4 |
SCM
Suffolk Capital Management
New York
|
+$573K |
| 5 |
Primecap Management
Pasadena,
California
|
+$414K |
Top Sellers
| 1 | -$97.5M | |
| 2 | -$3.42M | |
| 3 | -$2.16M | |
| 4 |
B
Bailard
Foster City,
California
|
-$1.31M |
| 5 |
Millennium Management
New York
|
-$674K |